Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.820
+0.060 (3.41%)
Mar 6, 2026, 4:00 PM EST - Market closed
Coherus Oncology Employees
Coherus Oncology had 228 employees as of December 31, 2024. The number of employees decreased by 78 or -25.49% compared to the previous year.
Employees
228
Change (1Y)
-78
Growth (1Y)
-25.49%
Revenue / Employee
$1,757,772
Profits / Employee
$980,829
Market Cap
272.04M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 222 |
| AC Immune | 172 |
| Abeona Therapeutics | 136 |
| OmniAb | 114 |
| Enlivex | 71 |
| Orchestra BioMed Holdings | 70 |
| Cybin | 50 |
| Surrozen | 41 |
CHRS News
- 5 days ago - Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 - GlobeNewsWire
- 12 days ago - Coherus Oncology to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 18 days ago - Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock - GlobeNewsWire
- 23 days ago - Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 7 weeks ago - Coherus Oncology, Inc. (CHRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114) - GlobeNewsWire
- 2 months ago - Coherus Oncology: A Two-Pronged March With Mid-2026 Implications - Seeking Alpha